PRD Therapeutics Pipeline
| Drug | Indication | Phase |
|---|
| PRD001 | Homozygous Familial Hypercholesterolemia (HoFH) | Phase 1 |
| PRD002 | HoFH and MASH/MASLD | Discovery/Lead Optimization |
| PRD003 | Lysosomal Acid Lipase Deficiency (LAL-D) | Discovery |
| PRD004 | Dyslipidemia | Discovery |